India to Iraq: Vancomycin Export Trade Route
India has recorded 59 verified shipments of Vancomycin exported to Iraq, representing a combined trade value of $1.7M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $29.2K USD. The leading Indian exporter is VENUS REMEDIES LIMITED, which accounts for 50% of total export value with 11 shipments worth $853.8K USD. On the buying side, P C F P I is the largest importer in Iraq with $697.9K USD in purchases. The top 3 suppliers — VENUS REMEDIES LIMITED, LYKA LABS LIMITED , IORA LIFECARE PRIVATE LIMITED — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Vancomycin corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $1.7M USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 50% of all export value, reflecting the consolidated nature of India's vancomycin manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $29.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with vancomycin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 28.4%, placing it at rank #20 among India's top vancomycin export destinations globally.
On the import side, key buyers of Indian vancomycin in Iraq include P C F P I, AL NIMAA SCIENTIFIC BUREAU , ORANGE PHARMA SCIENTIFIC BUREAUPARK AL SAADOON and 21 others. P C F P I is the single largest importer with 9 shipments valued at $697.9K USD.
Route Characteristics
- Average transit25 days
